LabCentral

@labcentral

LabCentral is the premier laboratory facility for next-generation powerhouse biotech startups. Home to 75 great teams and growing fast!

700 Main Street, Cambridge MA
labcentral.org
Vrijeme pridruživanja: studeni 2010.
Rođen/a 15. studenoga
523 fotografije ili videozapisa Fotografije i videozapisi

Tweetovi

Blokirali ste korisnika/cu @labcentral

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @labcentral

  1. Prikvačeni tweet
    1. lis 2019.

    Today we announce LabCentral 238, a new 100,000 sq. ft. facility focusing on bridging the gap many startups face as they move into process development. Thank you and for your support as we begin this next phase! More here:

    24 proslijeđena tweeta 57 korisnika označava da im se sviđa
    Poništi
  2. prije 24 sata

    Things are moving fast as lobby renovations at 700 Main heat up. Prep work on the steal structure for our new staircase has begun, framing and plumbing is in place for our new restroom, and headers are now in for our new secondary entrance portal and lobby conference room! – mjesto: LabCentral

    1 reply 1 proslijeđeni tweet 8 korisnika označava da im se sviđa
    Poništi
  3. 3. velj

    The latest from the Boston Globe, featuring alumni Audion, highlights the challenges gene therapy and regenerative medicine companies in hearing loss are facing despite promising technologies, funding, and big demand. Read more:

    5 proslijeđenih tweetova 10 korisnika označava da im se sviđa
    Poništi
  4. 29. sij

    Our annual party is in full swing in Harvard Square’s theatre. We can’t wait to see what NEON surprises you all have in store for us...the night is young!

    Korisnici , , i
    4 proslijeđena tweeta 39 korisnika označava da im se sviđa
    Poništi
  5. 28. sij

    Our latest exhibit at , "It's a Little Personal", pays homage to 3 trans and GNC artists; their works exploring identity, the body, and societal constraints. Stop by the gallery for insight into their minds and join the conversation around their unique perspectives.

    1 proslijeđeni tweet 7 korisnika označava da im se sviđa
    Poništi
  6. proslijedio/la je Tweet
    28. sij

    Congratulations , & teams to your amazing announcement today: $50M Series A, led by to address inflammatory diseases. Great to have you around , we wish you success for your important work !

    1 reply 2 proslijeđena tweeta 21 korisnik označava da mu se sviđa
    Poništi
  7. 27. sij

    Today from : “Especially in their early years, the close relationship to the founding labs is essential” for young biotech businesses trying to turn academic research into marketable products, notes . Read more:

    1 proslijeđeni tweet 11 korisnika označava da im se sviđa
    Poništi
  8. 15. sij

    Things are ch-ch-ch-changing here at our 700 Main Street site. Demo is well underway this week as we officially kick off our 4-month Lobby renovation. Be sure to check out all the improvements this Summer when we re-open the new Lobby for our resident startups & their guests! – mjesto: LabCentral

    2 proslijeđena tweeta 29 korisnika označava da im se sviđa
    Poništi
  9. proslijedio/la je Tweet
    10. sij

    See enjoying the big new construction project he is overseeing at ? Bigger and better lobby space coming for his team to organize our signature events. residents&visitors-thank you for your patience with this-we’ll come out better at the end!

    3 proslijeđena tweeta 23 korisnika označavaju da im se sviđa
    Poništi
  10. 9. sij

    LabCentral resident has seen incredible achievement over the years & shows no signs of slowing down…w/ their next big milestone focused on funding & drug development. Find out more about their research & ideas on our blog :

    1 proslijeđeni tweet 5 korisnika označava da im se sviđa
    Poništi
  11. 7. sij

    All work and no reward? Another great article on the multiple challenges facing biotech companies developing new antibiotics. Read the full article in :

    15 proslijeđenih tweetova 7 korisnika označava da im se sviđa
    Poništi
  12. proslijedio/la je Tweet
    19. pro 2019.

    We are super excited to announce that will be part of the visionary expansion delivered by , & partners at 's new development project, the . This project will transform 's innovation scene.

    11 proslijeđenih tweetova 58 korisnika označava da im se sviđa
    Poništi
  13. proslijedio/la je Tweet
    18. pro 2019.

    Sighted at ⁦⁩ : very competitive entries to our contest this year by the team from ⁦@BioInnovationVC⁩ !

    3 proslijeđena tweeta 31 korisnik označava da mu se sviđa
    Poništi
  14. 17. pro 2019.

    Over at LabCentral 610, is working on delivering hope for the holidays by preparing activity packages for hospitalized children with . Awesome work guys!

    1 proslijeđeni tweet 5 korisnika označava da im se sviđa
    Poništi
  15. 17. pro 2019.

    Thank you to for their continued support throughout the years. We're looking forward to what 2020 holds for us all!

    Looking back on the year that was. In Oct. a $5 million grant to was announced for a new resource for our ecosystem. LabCentral 238 will be a fully functional laboratory with a focus on scale-up . 🔗
    2 proslijeđena tweeta 18 korisnika označava da im se sviđa
    Poništi
  16. 16. pro 2019.

    Have you read our new blog post by ? It was just featured on - check it out to hear his perspective on why biopharma has abandoned new antibiotic development:

    2 proslijeđena tweeta 5 korisnika označava da im se sviđa
    Poništi
  17. 12. pro 2019.

    New on our blog: “VCs will tolerate biology risk, they like clinical risk, but they will not go near a venture where there is major commercial risk of failure.” explains why VCs are staying away from funding companies developing antibiotics

    8 proslijeđenih tweetova 12 korisnika označava da im se sviđa
    Poništi
  18. 11. pro 2019.

    Congratulations are in order for this year's Golden Ticket winners: and ! With Amgen's support, these teams have secured one free year of bench space for one scientist . Huzzah!

    5 proslijeđenih tweetova 19 korisnika označava da im se sviđa
    Poništi
  19. 5. pro 2019.

    The LabCentral 610 “Winter Warm-Up” hosted in partnership with CTI is underway! Thank you to and for sharing updates on their revolutionary technologies with the community.

    1 proslijeđeni tweet 17 korisnika označava da im se sviđa
    Poništi
  20. 4. pro 2019.

    Tonight: Join for “Science and a Screening: 5B Documentary” at the Marriott Cambridge at 5 PM. This doc tells the story of nurses at SF Gen. Hospital, who devoted themselves to HIV patients in the ’80s, just before the start of the epidemic. More:

    3 proslijeđena tweeta 3 korisnika označavaju da im se sviđa
    Poništi
  21. 3. pro 2019.

    In the 2019 roundup, companies, and Shape Tx are highlighted for their ground-breaking RNA-editing technologies. Alumni and protein degradation also mentioned as having made big strides in 2019. Read more here:

    1 proslijeđeni tweet 3 korisnika označavaju da im se sviđa
    Poništi

@labcentral još nije objavio nijedan Tweet.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·